Diabetes Insights - Breakthroughs and Innovators Podcast Por EASD - European Association for the Study of Diabetes arte de portada

Diabetes Insights - Breakthroughs and Innovators

Diabetes Insights - Breakthroughs and Innovators

De: EASD - European Association for the Study of Diabetes
Escúchala gratis

EASD presents: Diabetes Insights - Breakthroughs and Innovators Join us for expert interviews and discussions on the latest advances in diabetes research. Discover how groundbreaking medicines and cutting-edge technologies are shaping the future of diabetes treatment and management. Get inspired by the stories of distinguished researchers whose discoveries and contributions have transformed our understanding of diabetes. These podcasts were recorded at an EASD Annual Meeting. You can learn more about the research discussed by watching the scientific presentations in the EASD Media Centre (https://www.easd.org/media-centre/). New episode released every Friday. Ciencia Higiene y Vida Saludable
Episodios
  • Diabetologist and Psychologist: How to harness each other's skills?

    Diabetologist and Psychologist: How to harness each other's skills?
    Mar 27 2026
    In this episode, leading experts Maciej T. Małecki, Norbert Hermanns and Dominic Ehrmann explore the essential role of clinical psychology in diabetes care. Living with diabetes, particularly type 1 diabetes, requires constant decision-making and places a significant psychological burden on individuals and their families. From diabetes distress and depression to fear of hypoglycaemia, mental health challenges can directly impact glycaemic control and quality of life. This discussion highlights why clinical psychologists must be integrated into multidisciplinary diabetes teams, the need for specialised “diabetes psychologists,” and how education, guidelines and policy change can help address current gaps in care.
    Más Menos
    11 m
  • The Future of Scientific Publishing: Trust, Transparency and Turbulence

    The Future of Scientific Publishing: Trust, Transparency and Turbulence
    Mar 20 2026
    In this episode, we explore the rapidly evolving world of scientific publishing and the challenges facing researchers today, featuring insights from Diabetologia Editor in Chief Prof. Hindrik Mulder, Maria Hodges, Past EASD Early Career Member Pierre Larraufie and Annette Schürmann. From the rise of predatory journals and paper mills to the growing influence of artificial intelligence, the landscape is becoming increasingly complex. Our experts discuss how open access has reshaped publishing, why peer review remains essential, and the pressures placed on early career researchers navigating where and how to publish. They also explore the limitations of impact factors, the risks of fraudulent data, and the urgent need for new ways to evaluate scientific contribution. Join us for a timely conversation on how the research community can safeguard quality, transparency, and trust in science and what the future of publishing might look like.
    Más Menos
    20 m
  • Towards arresting type 1 diabetes: Breaking results of the MELD-ATG & Ver-A-T1D trials

    Towards arresting type 1 diabetes: Breaking results of the MELD-ATG & Ver-A-T1D trials
    Mar 13 2026
    In this episode, Prof. Chantal Mathieu and Prof. Francesco Dotta discuss two major European clinical trials presented at the EASD Annual Meeting: MELD-ATG and VERA-T1D. Both studies were conducted through the INNODIA consortium, a large European collaboration aimed at identifying biomarkers and testing new disease-modifying therapies for type 1 diabetes. The VERA-T1D trial investigated verapamil, a long-established cardiovascular drug, for its potential to preserve beta cell function after diagnosis. While the study narrowly missed its primary endpoint, the results provide important insights into disease heterogeneity and future combination therapies. The MELD-ATG trial used an innovative adaptive trial design to identify an effective low dose of anti-thymocyte globulin (ATG), showing that a single low-dose infusion may help delay beta-cell decline in newly diagnosed patients. Together, these studies highlight the rapid progress being made in type 1 diabetes research and the growing move toward precision medicine approaches.
    Más Menos
    17 m
Todavía no hay opiniones